New keyhole surgery for salivary gland tumors shows promise
NCT ID NCT07600112
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new, minimally invasive keyhole surgery (endoscopic parotidectomy) to the standard open surgery for removing benign (non-cancerous) tumors from the parotid gland, a major salivary gland. The goal is to see if the keyhole approach is as safe and effective, with better cosmetic results and fewer complications. The study involves 46 adults with small, superficial tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Endoscopic parotidectomy (minimally invasive surgery)
- What this could lead to
- If successful, this could offer patients a less invasive option for removing benign parotid tumors, with smaller scars and potentially faster recovery.
- What could go wrong
- This is a small, early-stage study with only 46 participants, so results may not apply to everyone. The endoscopic technique may not be suitable for all tumor types or sizes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PAROTID TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of General Surgery, Maxillofacial and Head and Neck Unit
Asyut, 2063045, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.